In order to assess if this reduction of NKG2D surface expression on NK cells from patients with B-CLL is functionally significant we then determined the ability of NK cells to mediate NKG2D-dependent cytotoxicity. This evidence concerns the gene KLRK1 and B-cell chronic lymphocytic leukemia.